SCHEMBL25025331

SCHEMBL25025331

CCC(C)(C)c1c(C(C)(C)C)nn2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.35
DRD4 P21917 2/20 0.35
DRD3 P35462 2/20 0.35
ALDH1A1 P00352 3/20 0.33
MIF P14174 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
PDE5A O76074 2/20 0.33
PDE4B Q07343 2/20 0.33
HTR1A P08908 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
PDE4A P27815 1/20 0.33
ADORA2A P29274 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12997416 0.85 ALDH1A1 (0.38) DRD2DRD4DRD3ALDH1A1MIF
SCHEMBL25054356 0.78 MMP7 (0.39) DRD2DRD4DRD3ALDH1A1MIF
SCHEMBL6494096 0.75 ALDH1A1 (0.38) DRD2DRD4DRD3ALDH1A1MIF
SCHEMBL26029443 0.74 ALDH1A1 (0.36) DRD2DRD4DRD3ALDH1A1MIF
SCHEMBL24415150 0.74 HDAC1 (0.38) DRD2DRD4DRD3ALDH1A1MIF
SCHEMBL6494091 0.73 PDE5A (0.36) DRD2DRD4DRD3ALDH1A1MIF
SCHEMBL26189772 0.73 EGFR (0.37) DRD2DRD4DRD3ALDH1A1MIF
SCHEMBL24656168 0.71 ALDH1A1 (0.41) DRD2DRD4DRD3ALDH1A1MIF
SCHEMBL23638695 0.71 SLC9A1 (0.35) DRD2DRD4DRD3
SCHEMBL25024692 0.71 PDE4B (0.43) DRD2DRD4DRD3ALDH1A1MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230051320-A1 TETRAHYDROPYRAZOLO-PYRAZINYL-DIHYDROIMIDAZOLONE OR TETRAHYDROPYRAZOLO-PYRIDINYL-DIHYDROIMIDAZOLONE COMPOUNDS AND METHODS OF USING SAME ECCOGENE INC. 2023-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230051320-A1 TETRAHYDROPYRAZOLO-PYRAZINYL-DIHYDROIMIDAZOLONE OR TETRAHYDROPYRAZOLO-PYRIDINYL-DIHYDROIMIDAZOLONE COMPOUNDS AND METHODS OF USING SAME GLP1R, SLC5A1, GIPR DRD2 3324/4885DRD4 3411/4885DRD3 2088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.